Registry of diagnostics and treatment outcomes in patients with cardiogenic shock in Poland
Polish Nationwide Registry of Diagnostics, Treatment and Outcome in Patients With Cardiogenic Shock CaS-POL
This study is collecting information on how patients with cardiogenic shock are diagnosed and treated in Poland to see how well current treatments work and where improvements can be made.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Wroclaw Medical University Academic / other |
| Locations | 2 sites (Wroclaw, Lower Silesian Voivodeship and 1 other locations) |
| Trial ID | NCT06697093 on ClinicalTrials.gov |
What this trial studies
This registry aims to gather comprehensive data on the epidemiology, diagnostics, treatment, and outcomes of patients experiencing cardiogenic shock in Poland. It will involve participation from various cardiology departments equipped with 24-hour hemodynamic laboratories, collecting data through electronic case report forms. The study will focus on understanding the current state of treatment, including the use of mechanical circulatory support, to identify areas for improvement in patient care. Data will be collected over a six-month period, followed by a six-month observation phase to track patient outcomes.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 years old experiencing cardiogenic shock of various etiologies in SCAI stages B, C, D, or E.
Not a fit: Patients with primary septic, anaphylactic, or hypovolemic shock, as well as those in end-stage heart failure, will not benefit from this registry.
Why it matters
Potential benefit: If successful, this initiative could lead to improved treatment protocols and outcomes for patients suffering from cardiogenic shock.
How similar studies have performed: While this registry approach is not widely tested, similar initiatives have shown promise in improving treatment outcomes for cardiogenic shock in other regions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Cardiogenic shock patients of all etiologies in SCAI stage B, C, D, E. * age \> 18 years old * persistent hemodynamic failure defined as systolic blood pressure of \<90 mmHg for ≥ 30 minutes or the requirement for inotropic or vasopressor agents with evidence of hypoperfusion of the peripheral organs Exclusion Criteria: * patients without return of spontaneous circulation who were considered to extracorporeal cardiopulmonary resuscitation (ECPR) * primary septic, anaphylactic, hypovolemic shock * post-operative cardiogenic shock * end-stage of heart failure disqualified from mechanical circulatory support and heart transplantation
Where this trial is running
Wroclaw, Lower Silesian Voivodeship and 1 other locations
- Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland — Wroclaw, Lower Silesian Voivodeship, Poland (Not_yet_recruiting)
- Wroclaw Medical University — Wroclaw, Poland (Recruiting)
Study contacts
- Study coordinator: Wiktor Kuliczkowski, MD,PhD
- Email: wiktor.kuliczkowski@umw.edu.pl
- Phone: +48 71 736 42 51
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.